首页
400-620-6333
切换导航
搜索
基本描述
| 规格或纯度 | ≥98% |
|---|---|
| 英文名称 | Pralatrexate |
| 别名 | Folotyn;10-propargyl-10-deazaaminopterin;N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid |
| 英文别名 | Folotyn;10-propargyl-10-deazaaminopterin;N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid |
| 生化机理 | Pralatrexate acts an inhibitor of DHFR (dihydrofolate reductase). |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 备注 | 卖完停产，不再备货 |
| 产品介绍 |
An inhibitor of DHFR (dihydrofolate reductase) An inhibitor of DHFR (dihydrofolate reductase) |
名称和标识符
| IUPAC Name | (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid |
|---|---|
| INCHI | InChI=1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1 |
| InChi Key | OGSBUKJUDHAQEA-WMCAAGNKSA-N |
| Canonical SMILES | C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O |
| PubChem CID | 148121 |
| 分子量 | 477.47 |
数据库链接
| DrugBank Ligand | DB06813 |
|---|---|
| PubChem CID | 148121 |
| CAS Registry No. | 146464-95-1 |
| ChEMBL Ligand | CHEMBL1201746 |
| Wikipedia | Pralatrexate |
| DrugCentral Ligand | 4117 |
化学和物理性质
| 溶解性 | Soluble in DMSO (28 mg/ml at 25 °C), water (<1 mg/ml at 25 °C), and ethanol (<1 mg/ml at 25 °C). Insoluble in chloroform. |
|---|
安全和危险性（GHS）
| 象形图 |
Toxic 
Health Hazard 
Harmful |
|---|---|
| 信号词 | Danger |
| 危险声明 |
H315: Causes skin irritation H319: Causes serious eye irritation H335: May cause respiratory irritation H301: Toxic if swallowed H311: Toxic in contact with skin H331: Toxic if inhaled H351: Suspected of causing cancer H372: Causes damage to organs through prolonged or repeated exposure H360: May damage fertility or the unborn child H340: May cause genetic defects |
| 预防措施声明 | P261,P305+P351+P338,P280,P302+P352,P321,P405,P501,P264,P260,P281,P271,P270,P304+P340,P403+P233,P362+P364,P330,P361+P364,P203,P264+P265,P301+P316,P318,P337+P317,P332+P317,P316,P319 |
关联配体
| Ligand ID | 6840 |
|---|---|
| 名称 | pralatrexate |
| 别名 | Folotyn® |
| 类别 | Synthetic organic |
| 学名 | (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid |
| 生物活性评价 |
The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in |
| 评价 |
Inhibits dihydrofolate reductase, GAR transformylase and thymidylate synthase. The INN document specifies that pralatrexate is a racemic mixture of two epimers. These epimers are represented by the PubChem entries CID 23230419 and CID 11155808. We do not specify stereochemistry at the carbon atom which determines the two epimers, therefore our image represents the mixture. SARS-CoV-2 and COVID-19: Pralatrexate has been identified as an inhibitor of the viral RNA-dependent RNA polymerase (RdRp; nsp12) from SARS-CoV-2 |
产品问答
产品问答
参考文献
| 1. Zhang H, Yang Y, Li J, Wang M, Saravanan KM, Wei J, Tze-Yang Ng J, Tofazzal Hossain M, Liu M, Zhang H et al.. (2020) A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro.. PLoS Comput Biol, 16 (12): (e1008489). [PMID:33382685] |
上海阿拉丁生化科技股份有限公司
? 2016 ALADDIN-E.COM . 版权所有,未经授权禁止拷贝本站资料,如有违反,将追究法律责任
危险品化学品经营许可证（带存储）